247499
Éthyl cellulose
viscosity 100 cP, 5 % in toluene/ethanol 80:20(lit.), extent of labeling: 48% ethoxyl
Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
About This Item
Produits recommandés
Forme
powder or granules
Niveau de qualité
Température d'inflammation spontanée
698 °F
Concentration
48.0-49.5%
Ampleur du marquage
48% ethoxyl
Indice de réfraction
n20/D 1.47 (lit.)
Viscosité
100 cP, 5 % in toluene/ethanol 80:20(lit.)
Température de transition
softening point 155 °C
Densité
1.14 g/mL at 25 °C (lit.)
Vous recherchez des produits similaires ? Visite Guide de comparaison des produits
Description générale
Ethyl cellulose is a non-toxic, physiologicallyinert, and stable hydrophobic polymer. It is widely used in the preparation ofsustained release matrices for drug delivery systems.
Application
Ethyl cellulose can be used:
- To prepare polymeric microcapsules of Alachlor and Metolachlor to study their controlled-release properties.
- As a core matrix to synthesize biphasic drug release nanofibers.
- To prepare wax-based solid dispersion pellets with excellent floating and sustained-release ability.
Code de la classe de stockage
11 - Combustible Solids
Classe de danger pour l'eau (WGK)
WGK 1
Point d'éclair (°F)
Not applicable
Point d'éclair (°C)
Not applicable
Équipement de protection individuelle
Eyeshields, Gloves, type N95 (US)
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Les clients ont également consulté
Sensors (Basel, Switzerland), 19(12) (2019-06-30)
Novel hot electron-emitting working electrodes and conventional counter electrodes were created by screen printing. Thus, low-cost disposable electrode chips for bioaffinity assays were produced to replace our older expensive electrode chips manufactured by manufacturing techniques of electronics from silicon or
IEEE transactions on bio-medical engineering, 67(8), 2337-2348 (2019-12-17)
Ethanol ablation, the injection of ethanol to induce necrosis, was originally used to treat hepatocellular carcinoma, with survival rates comparable to surgery. However, efficacy is limited due to leakage into surrounding tissue. To reduce leakage, we previously reported incorporating ethyl
Acta poloniae pharmaceutica, 69(1), 11-22 (2012-05-12)
Ethylcellulose (EC) based microencapsulated drug delivery systems are being extensively studied throughout the world for achieving extended drug release and protecting the core substance from degradation. The in vitro evaluation of EC microcapsules have elucidated that their particle characteristics are
Biological & pharmaceutical bulletin, 35(11), 1926-1931 (2012-11-06)
Production of drug nanoparticles is an effective strategy to enhance solubility and oral absorption of water-insoluble drugs. The handling of drug nanoparticles has been an important issue in drug formulation because nanoparticles easily aggregate each other and redispersion of these
Pharmaceutical research, 30(1), 225-237 (2012-09-08)
To investigate a new microfluidic method for the continuous preparation of hollow-shell nanoparticles of a hydrophobic polymer and the simultaneous encapsulation within these of a hydrophilic active pharmaceutical ingredient. A specially designed and constructed microfluidic device which facilitates at a
Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..
Contacter notre Service technique